|
|
Introducing the Class of 2019 MGH Research Scholars
|
|
|
|
|
We are delighted to introduce you to our five new MGH Research Scholars. Thanks to the visionary support of philanthropists like you, we have been able to give out 60 awards since the program launched in 2011.
|
|
|
|
|
Jodie Babitt, MD
Dr. Babitt is a researcher in the Department of Medicine studying how cells and organisms regulate their iron content, and how this process goes awry in many common diseases.
|
|
|
|
|
Dara S. Manoach, PhD
Dr. Manoach is a researcher in the Department of Psychiatry exploring new ways to treat schizophrenia by targeting patterns of brain waves known as sleep spindles.
|
|
|
|
|
Miguel N. Rivera, MD
Dr. Rivera is a researcher in the Department of Pathology investigating how abnormal gene regulation helps to drive growth in pediatric bone and brain cancers.
|
|
|
|
|
Natalia S. Rost, MD, MPH
Dr. Rost is a researcher in the Department of Neurology working to understand why individuals become susceptible to strokes and to develop new strategies for stroke prevention.
|
|
|
|
|
Amar Sahay, PhD
Dr. Sahay is a researcher in the Department of Psychiatry studying the mechanisms of nerve cells to develop new strategies to improve memory in adulthood and aging.
|
|
|
|
|
|
A Closer Look at Exercise and Depression
|
|
|
|
|
|
|
A research team led by Jordan Smoller, MD, ScD, Tepper Family MGH Research Scholar 2014-2019, recently published a study that took a closer look at the genetic links between exercise and depression. Learn more.
|
|
|
|
|
|
Mitochondrial "Leakiness" Contributes to Heart Attack and Stroke Damage
|
|
|
|
|
A team led by Alexander Soukas, MD, PhD, Weissman Family MGH Research Scholar 2018-2023, recently published a study detailing how changes in the permeability of mitochondrial membranes can impact cellular health.
These insights could help to limit the damage caused by heart attacks and strokes and to develop new strategies to reduce the negative health effects of aging. Learn more.
|
|
|
|
|
|
Blood Cell Study Could Improve Lung Cancer Treatments
|
|
|
|
|
Mikael Pittet, PhD, Samana Cay MGH Research Scholar 2015-2020, recently conducted a single-cell analysis of a subset of blood cells called myeloid cells in human and mouse models of lung cancer.
The team found that myeloid cell types are consistent across lung cancer patients and identified new treatment targets that could improve cancer immunotherapies. Learn more.
|
|
|
|
|
|
A Promising New Approach to Treating Diseases of the Brain
|
|
|
|
|
Deposits of tau protein in the brain are associated with diseases such as Alzheimer's disease and frontotemporal dementia.
A team led by Stephen Haggarty, PhD, Stuart and Suzanne Steele MGH Research Scholar 2017-2022, developed a tool that cleared tau deposits and improved the health of neurons derived from patients with frontotemporal dementia.
This tool could lead to new strategies for treating diseases that stem from abnormal deposits of protein in the brain. Learn more.
|
|
|
|
|
|
Breton Discusses the Thrill of Discovery on Mass General's Charged Podcast
|
|
|
|
|
Sylvie Breton, PhD, Charles and Ann Saunders MGH Research Scholar 2011-2016, and the inaugural incumbent of the Richard Moerschner Endowed MGH Research Institute Chair in Men's Health, was recently featured on Mass General's Charged podcast.
Dr. Breton has identified a method for predicting the onset of acute kidney disorder, which affects more than four million people yearly and is called the silent killer.
On the podcast, she talks about why she enjoys research and how each discovery spurs her on to the next. Learn more.
|
|
|
|
|
|
| McClatchey Honored with Endowed Chair in Oncology |
|
|
|
|
|
|
Pictured, from left, David Louis, MD, Chief of Pathology; Andrea McClatchey, PhD; Patricia Poitras; James Poitras; and Daniel Haber, MD, PhD, Director of the Cancer Center
|
|
|
|
|
Andrea McClatchey, PhD, Patricia and Scott Eston MGH Research Scholar 2011-2016, has been honored as the inaugural incumbent of the Poitras Family Endowed Chair in Oncology.
The chair was made possible by James and Patricia Poitras. This is the second endowed chair established by the family, the first being the James and Patricia Poitras Endowed Chair in Cancer Research.
|
|
|
|
|
|
